App for people with hypertrophic cardiomyopathy begins trials

9th April 2015

A hospital in America is piloting a new app to help people diagnosed with hypertrophic cardiomyopathy get improved individualised treatment and stay out of hospital.

The app, iGetBetter, is designed to monitor patients symptoms and encourage them to comply with post-discharge advice and lessen the need for hospital care.

The app is being trialled at the Brigham and Women’s Hospital in Boston, a leading centre for treating cardiomyopathy.

Dr Neal Lakdawala, a doctor at the hospital and the clinical lead on the project, said: “We are excited about the potential for this pilot, in which we will accelerate the pace of relief for patients using technology that allows them to report symptoms, vital signs, and step counts daily. This information will allow us to increase their medications weekly and individualise treatment.”

With iGetBetter’s system, patients can review their personalised care plans on a patient-facing HTML5 web app, designed to work on various devices, including Android and iOS ones. The app allows patients to view announcements and reminders, log their progress, manage their contact information, and communicate with care team members.

Dr Lakdawala added: “There is a great need for innovative approaches to relieve symptoms for patients with hypertrophic cardiomyopathy. Symptoms can vary significantly on a day to day, and even minute to minute basis, but contemporary practice has not adapted to this aspect of disease.”

Dr David Lebudzinski, chief medical officer at iGetBetter said “For the first time, we will be using daily patient biometric readings coupled with daily subjective inputs from patients about possible cardiac symptoms to titrate medication levels to maximum desired levels remotely without the need for multiple outpatient visits. This potentially represents a major improvement for hypertrophic cardiomyopathy patients who will be brought up to desired medication doses faster than ever, achieving a level of therapeutic safety much faster than in the past. This should improve their quality of life and reduce their risk for adverse cardiac events very quickly.”

There are now many apps on the market to help people with cardiomyopathy, including one produced by Cardiomyopathy UK